Stockscreener 앱 받기
13.75
3.35%
-0.59
시간 외 거래:
13.75
전일 마감가:
$14.34
열려 있는:
$14.23
하루 거래량:
76,523
Relative Volume:
1.29
시가총액:
$364.60M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+10.44%
1개월 성능:
-4.41%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$13.61
$14.34
1주일 범위
$12.02
$14.60
52주 변동 폭
$11.81
$15.10
Carlsmed Inc Stock (CARL) Company Profile
CARL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
13.75 | 349.48M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
286.63 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
76.32 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.09 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.33 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.14 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 개시 | BTIG Research | Buy |
| 2025-08-18 | 개시 | BofA Securities | Buy |
| 2025-08-18 | 개시 | Goldman | Buy |
| 2025-08-18 | 개시 | Piper Sandler | Overweight |
| 2025-08-18 | 개시 | Truist | Buy |
Carlsmed Inc 주식(CARL)의 최신 뉴스
Carlsmed initiated with Buy at Truist on business potential - MSN
Why Is Carlsmed Stock Gaining Monday?Carlsmed (NASDAQ:CARL) - Benzinga
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Carlsmed initiated with Buy at Truist on business potential (CARL) - Seeking Alpha
BofA Securities Initiates Coverage on Carlsmed With Buy Rating, $16 Price Target - MarketScreener
This Synaptics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Goldman Sachs Initiates Coverage on Carlsmed With Buy Rating, $19 Price Target - MarketScreener
Truist Securities initiates coverage on Carlsmed stock with Buy rating - Investing.com
Truist Initiates Carlsmed at Buy With $18 Price Target - MarketScreener
Piper Sandler initiates coverage on Carlsmed with an Overweight rating, PT of $18. - AInvest
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech - Investing.com
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech By Investing.com - Investing.com South Africa
Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential - Investing.com India
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating - Investing.com
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Nigeria
Carlsmed initiated with a Buy at Goldman Sachs - MSN
AI medtech firm Carlsmed to sell 6.7M shares in IPO - MSN
Carlsmed, Inc. shares fall 2.01% after-hours as it prepares to report Q2 2025 financial results. - AInvest
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - The Manila Times
Carlsmed to report Q2 2025 financial results on Aug 28, 2025. - AInvest
Big Boost for Personalized Cervical Fusion: Add-On Code - Orthopedics This Week
Heartflow raises $317M, pops 66% at market open - BioWorld MedTech
Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry
Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News
Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛
Carlsmed's Aprevo Personalized Interbody Implants Receive CMS NTAP for Cervical Fusion Procedures - AInvest
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg.com
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener
Carlsmed announces completion of first aprevo cervical procedure - TipRanks
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery. - AInvest
Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle
Carlsbad-based medical technology company begins trading on Nasdaq - MSN
Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP
Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener
Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com South Africa
Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com India
Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia
Carlsmed director Philip Young buys $900k in shares - Investing.com
Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com India
Carlsmed director Mittendorff buys $20 million in shares - Investing.com
Carlsmed Inc (CARL) 재무 분석
Carlsmed Inc (CARL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Carlsmed Inc 주식 (CARL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sidow Kevin | Director |
Jul 24 '25 |
Buy |
15.00 |
13,333 |
199,995 |
59,566 |
| Mittendorff Robert II | Director |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
| ROOT JONATHAN D | Director |
Jul 24 '25 |
Buy |
15.00 |
466,666 |
6,999,990 |
483,999 |
| YOUNG PHILIP M | Director |
Jul 24 '25 |
Buy |
15.00 |
59,999 |
899,985 |
53,333 |
0.74%
2.34%
자본화:
|
볼륨(24시간):